Substance / Medication

Carteolol

Overview

Active Ingredient
carteolol
RxNorm CUI
2116

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
A prospective study of topical carteolol therapy in Chinese infants with superficial infantile hemangioma.
Gan Li-Qiang, Wang Hua, Ni Si-Li et al. · Pediatr Dermatol · 2018
PMID: 29243341RCT
Efficacy and safety of the fixed combinations of tafluprost/timolol and latanoprost/carteolol.
Fuwa Masahiro, Shimazaki Atsushi, Mieda Masafumi et al. · Sci Rep · 2019
PMID: 31097790ObservationalFull text (PMC)
Comparison of carteolol plasmatic levels after repeated instillations of long-acting and regular formulations of carteolol 2% in glaucoma patients.
Renard P, Kovalski J L, Cochereau I et al. · Graefes Arch Clin Exp Ophthalmol · 2005
PMID: 16003515Observational
In vitro evidence that carteolol is a nonconventional partial agonist of guinea pig cardiac beta1-adrenoceptors: a comparison with xamoterol.
Floreani Maura, Froldi Guglielmina, Quintieri Luigi et al. · J Pharmacol Exp Ther · 2005
PMID: 16160085Observational
Characterization of intrinsic sympathomimetic activity of carteolol in rat cardiovascular preparations.
Floreani Maura, Froldi Guglielmina, Cavalli Maurizio et al. · J Pharmacol Sci · 2004
PMID: 15153658Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Carteolol (substance)
SNOMED CT
386866004
UMLS CUI
C0007299
RxNorm CUI
2116

Clinical Data

This intervention maps to 3 entities in the Healos knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.